4/3
01:06 pm
stro
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Low
Report
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
4/3
01:06 pm
stro
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Low
Report
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
4/3
10:16 am
stro
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
Low
Report
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
4/3
10:05 am
stro
Rating for STRO
Medium
Report
Rating for STRO
4/3
10:05 am
stro
Rating for STRO
Medium
Report
Rating for STRO
4/3
08:31 am
stro
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $17.00 price target on the stock.
Low
Report
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $17.00 price target on the stock.
4/3
08:31 am
stro
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $17.00 price target on the stock.
Low
Report
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $17.00 price target on the stock.
4/3
08:21 am
stro
Rating for STRO
Low
Report
Rating for STRO
4/3
08:21 am
stro
Rating for STRO
Low
Report
Rating for STRO
3/28
07:42 am
stro
Rating for STRO
High
Report
Rating for STRO
3/28
07:42 am
stro
Rating for STRO
High
Report
Rating for STRO
3/27
08:07 am
stro
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
High
Report
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
3/27
07:40 am
stro
Rating for STRO
High
Report
Rating for STRO
3/27
07:40 am
stro
Rating for STRO
High
Report
Rating for STRO
3/26
09:36 am
stro
Rating for STRO
High
Report
Rating for STRO
3/26
09:36 am
stro
Rating for STRO
High
Report
Rating for STRO
3/26
08:39 am
stro
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $17.00 price target on the stock.
High
Report
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $17.00 price target on the stock.
3/26
08:39 am
stro
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $17.00 price target on the stock.
High
Report
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $17.00 price target on the stock.
3/26
08:31 am
stro
Rating for STRO
High
Report
Rating for STRO
3/26
08:31 am
stro
Rating for STRO
High
Report
Rating for STRO